Hyperimmunoglobulinemia and IgG Subclass Abnormalities in Children With Gaucher Disease

被引:1
作者
Marzouk, Iman [1 ]
Deghady, Akram [2 ]
Omar, Omneya M. [1 ]
Ashour, Rofaida S. [1 ]
机构
[1] Alexandria Univ, Dept Pediat, Fac Med, Alexandria, Egypt
[2] Alexandria Univ, Dept Clin Pathol, Fac Med, Alexandria, Egypt
关键词
Gaucher disease; hyperimmunoglobulinemia; IgG subclass; ENZYME REPLACEMENT THERAPY; IMMUNOGLOBULIN; SERUM;
D O I
10.1097/MPH.0000000000001574
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gaucher disease (GD) is the most common lysosomal storage disorder, the aim of the current study was to investigate hyperimmunoglobulinemia and abnormalities of serum immunoglobulin G (IgG) subclasses in children with GD and the relation of those findings to the GD phenotype and genotype, duration of enzyme replacement therapy (ERT), and infection frequency. The study included 20 Egyptian children with GD receiving ERT and 20 age-matched and sex-matched healthy children as controls. Serum Ig and serum IgG subclass levels were measured in the children with GD. Serum IgG subclass levels were measured in the control subjects. Hyperimmunoglobulinemia was present in 15 of the 20 (75%) children with GD. In addition, it is found significantly lower IgG2 levels and significantly higher IgG3 levels in the GD group than in the control group (P<0.001 and <0.006, respectively). Patients with 12 infections per year had significantly higher IgG3 levels compared with patients with 6 infections per year (P=0.022). In conclusion, hyperimmunoglobulinemia and IgG subclass abnormalities occur in children with GD who are on ERT and may be related to recurrent infections.
引用
收藏
页码:E416 / E420
页数:5
相关论文
共 26 条
[1]  
[Anonymous], 2013, ASIMPLE GUIDE IBM SP
[2]   Immunoglobulin Abnormalities and Effects of Enzyme Replacement Therapy in Children with Gaucher Disease [J].
Arikan-Ayyildiz, Zeynep ;
Yuce, Aysel ;
Uslu-Kizilkan, Nuray ;
Demir, Hulya ;
Gurakan, Figen .
PEDIATRIC BLOOD & CANCER, 2011, 56 (04) :664-666
[3]  
Barak V, 1999, EUR CYTOKINE NETW, V10, P205
[4]   South African guidelines for the management of Gaucher disease, 2011 [J].
Bhengu, Louisa ;
Davidson, Alan ;
du Toit, Paul ;
Gerntholtz, Trevor ;
Govendrageloo, Kenny ;
Heitner, Rene ;
Henderson, Bertram ;
Mubaiwa, Lawrence ;
Varughese, Sheeba .
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2012, 102 (08) :697-702
[5]  
Cormand B, 1998, AM J MED GENET, V80, P343, DOI 10.1002/(SICI)1096-8628(19981204)80:4<343::AID-AJMG8>3.0.CO
[6]  
2-W
[7]   Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature [J].
de Fost, M. ;
Out, T. A. ;
de Wilde, F. A. ;
Tjin, E. P. M. ;
Pals, S. T. ;
van Oers, M. H. J. ;
Boot, R. G. ;
Aerts, J. F. M. G. ;
Maas, M. ;
vom Dahl, S. ;
Hollak, C. E. M. .
ANNALS OF HEMATOLOGY, 2008, 87 (06) :439-449
[8]  
Deibener J, 1998, HAEMATOLOGICA, V83, P479
[9]  
El Gawhary S., 2013, Egypt J Med Hum Genet, V14, P361, DOI [10.1016/j.ejmhg.2013.06.002, DOI 10.1016/J.EJMHG.2013.06.002]
[10]   Glucosidase acid beta gene mutations in Egyptian children with Gaucher disease and relation to disease phenotypes [J].
El-Morsy, Zakarya ;
Khashaba, Mohamed T. ;
Soliman, Othman El-Sayed ;
Yahia, Sohier ;
Abd El-Hady, Dina .
WORLD JOURNAL OF PEDIATRICS, 2011, 7 (04) :326-330